ALC

Alcon Inc
76.20
-1.03 (-1.33%)
Upgrade to Real-Time
Afterhours (Closed)
76.20
Volume 777,998
Bid Price
Ask Price
News -
Day High 76.43

Low
55.21

52 Week Range

High
81.975

Day Low 75.30
Company Name Stock Ticker Symbol Market Type
Alcon Inc ALC NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.03 -1.33% 76.20 20:00:00
Open Price Low Price High Price Close Price Prev Close
75.30 75.30 76.43 76.25 77.23
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,138 777,998 $ 76.03 $ 59,152,370 - 55.21 - 81.975
Last Trade Time Type Quantity Stock Price Currency
19:00:00 17,992 $ 76.25 USD

Period:

Draw Mode:

Alcon Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 37.34B 490.09M 490.09M $ 8.29B $ 547.21M 0.76 64.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.11 0.28% 05/03/22 - -

more financials information »

Alcon News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week73.9777.9073.6575.84816,6172.233.01%
1 Month70.7677.9069.6774.18809,0205.447.69%
3 Months64.8377.9062.7269.59894,31411.3717.54%
6 Months77.2878.2255.2166.10934,327-1.08-1.4%
1 Year77.4781.97555.2169.64883,600-1.27-1.64%
3 Years58.9888.7839.3766.45982,47717.2229.2%
5 Years58.24588.7839.3764.371,040,80417.9630.83%

Alcon Description

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.